Toll-like receptor 2/4 links to free fatty acid-induced inflammation and β-cell dysfunction

Journal of Leukocyte Biology

Volumn 95, Issue 1, 2014, Pages 47-52

  Yin, Jiajing ^a   Peng, Yongde ^a   Wu, Jingcheng ^a   Wang, Yufan ^a   Yao, Lili ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Apoptosis; Autophagy; FFA; TLR 2 4; Type 2 diabetes

Indexed keywords

ADAPTOR PROTEIN; ADVANCED GLYCATION END PRODUCT RECEPTOR; FATTY ACID; INTERLEUKIN 1; MYELOID DIFFERENTIATION FACTOR 88; OXIDIZED LOW DENSITY LIPOPROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; AUTOPHAGY; CELL DEATH; CYTOKINE RELEASE; GLUCOSE METABOLISM; HUMAN; INFLAMMATION; INNATE IMMUNITY; INSULIN RELEASE; INSULIN RESISTANCE; LOSS OF FUNCTION MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE; SELECTIVE AUTOPHAGY; VASCULITIS; ANIMAL; APOPTOSIS; DIABETES MELLITUS; DRUG ANTAGONISM; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION; TLR 2/4;

APOPTOSIS; AUTOPHAGY; FFA; TLR 2/4; TYPE 2 DIABETES;

ANIMALS; APOPTOSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FATTY ACIDS; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84897018309     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0313143     Document Type: Review

References (75)

1. Chentouf, M., Dubois, G., Jahannaut, C., Castex, F., Lajoix, A. D., Gross, R., Peraldi-Roux, S. (2011) Excessive food intake, obesity and inflammation process in Zucker fa/fa rat pancreatic islets. PloS One 6, e22954.
2. Schenk, S., Saberi, M., Olefsky, J. M. (2008) Insulin sensitivity: modulation by nutrients and inflammation. J. Clin. Invest. 118, 2992-3002.
3. Odegaard, J. I., Chawla, A. (2012) Connecting type 1 and type 2 diabetes through innate immunity. Cold Spring Harb. Perspect. Med. 2, a007724.
4. Cavelti-Weder, C., Babians-Brunner, A., Keller, C., Stahel, M. A., Kurz-Levin, M., Zayed, H., Solinger, A. M., Mandrup-Poulsen, T., Dinarello, C. A., Donath, M. Y. (2012) Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes. Diabetes Care 35, 1654-1662.
5. Gurzov, E. N., Ortis, F., Cunha, D. A., Gosset, G., Li, M., Cardozo, A. K., Eizirik, D. L. (2009) Signaling by IL-1β+IFN-γ and ER stress converge on DP5/Hrk activation: a novel mechanism for pancreatic β-cell apoptosis. Cell Death Differ. 16, 1539-1550.
6. Rabinovitch, A., Suarez-Pinzon, W. L. (1998) Cytokines and their roles in pancreatic islet β-cell destruction and insulin-dependent diabetes mellitus. Biochem. Pharmacol. 55, 1139-1149.
7. Chae, C. U., Lee, R. T., Rifai, N., Ridker, P. M. (2001) Blood pressure and inflammation in apparently healthy men. Hypertension 38, 399-403.
8. Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z. W., Karin, M., Shoelson, S. E. (2001) Reversal of obesity-and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ. Science 293, 1673-1677.
9. Donath, M. Y., Shoelson, S. E. (2011) Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11, 98-107.
10. Kawai, T., Akira, S. (2009) The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 21, 317-337.
11. Tsan, M. F., Gao, B. (2004) Endogenous ligands of Toll-like receptors. J. Leukoc. Biol. 76, 514-519.
12. Osterloh, A., Breloer, M. (2008) Heat shock proteins: linking danger and pathogen recognition. Med. Microbiol. Immunol. 197, 1-8.
13. Chiu, Y. C., Lin, C. Y., Chen, C. P., Huang, K. C., Tong, K. M., Tzeng, C. Y., Lee, T. S., Hsu, H. C., Tang, C. H. (2009) Peptidoglycan enhances IL-6 production in human synovial fibroblasts via TLR2 receptor, focal adhesion kinase, Akt, and AP-1-dependent pathway. J. Immunol. 183, 2785-2792.
14. Hreggvidsdottir, H. S., Ostberg, T., Wahamaa, H., Schierbeck, H., Aveberger, A. C., Klevenvall, L., Palmblad, K., Ottosson, L., Andersson, U., Harris, H. E. (2009) The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J. Leukoc. Biol. 86, 655-662.
15. Rifkin, I. R., Leadbetter, E. A., Busconi, L., Viglianti, G., Marshak-Rothstein, A. (2005) Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol. Rev. 204, 27-42.
16. Wen, L., Peng, J., Li, Z., Wong, F. S. (2004) The effect of innate immunity on autoimmune diabetes and the expression of Toll-like receptors on pancreatic islets. J. Immunol. 172, 3173-3180.
17. Dasu, M. R., Devaraj, S., Park, S., Jialal, I. (2010) Increased Toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 33, 861-868.
18. Dasu, M. R., Devaraj, S., Zhao, L., Hwang, D. H., Jialal, I. (2008) High glucose induces Toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 57, 3090-3098.
19. Ladefoged, M., Buschard, K., Hansen, A. M. (2013) Increased expression of Toll-like receptor 4 and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes. APMIS 121, 531-538.
20. Amyot, J., Semache, M., Ferdaoussi, M., Fontes, G., Poitout, V. (2012) Lipopolysaccharides impair insulin gene expression in isolated islets of Langerhans via Toll-like receptor-4 and NF-κB signalling. PloS One 7, e36200.
21. Schwartz, E. A., Zhang, W. Y., Karnik, S. K., Borwege, S., Anand, V. R., Laine, P. S., Su, Y., Reaven, P. D. (2010) Nutrient modification of the innate immune response: a novel mechanism by which saturated fatty acids greatly amplify monocyte inflammation. Arterioscler. Thromb. Vasc. Biol. 30, 802-808.
22. Nguyen, M. T., Favelyukis, S., Nguyen, A. K., Reichart, D., Scott, P. A., Jenn, A., Liu-Bryan, R., Glass, C. K., Neels, J. G., Olefsky, J. M. (2007) A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J. Biol. Chem. 282, 35279-35292.
23. Goldberg, A., Parolini, M., Chin, B. Y., Czismadia, E., Otterbein, L. E., Bach, F. H., Wang, H. (2007) Toll-like receptor 4 suppression leads to islet allograft survival. FASEB J. 21, 2840-2848.
24. Schulthess, F. T., Paroni, F., Sauter, N. S., Shu, L., Ribaux, P., Haataja, L., Strieter, R. M., Oberholzer, J., King, C. C., Maedler, K. (2009) CXCL10 impairs β cell function and viability in diabetes through TLR4 signaling. Cell Metab. 9, 125-139.
25. Eguchi, K., Manabe, I., Oishi-Tanaka, Y., Ohsugi, M., Kono, N., Ogata, F., Yagi, N., Ohto, U., Kimoto, M., Miyake, K., Tobe, K., Arai, H., Kadowaki, T., Nagai, R. (2012) Saturated fatty acid and TLR signaling link β cell dysfunction and islet inflammation. Cell Metab. 15, 518-533.
26. Bollyky, P. L., Bice, J. B., Sweet, I. R., Falk, B. A., Gebe, J. A., Clark, A. E., Gersuk, V. H., Aderem, A., Hawn, T. R., Nepom, G. T. (2009) The Toll-like receptor signaling molecule Myd88 contributes to pancreatic β-cell homeostasis in response to injury. PloS One 4, e5063.
27. Hutton, M. J., Soukhatcheva, G., Johnson, J. D., Verchere, C. B. (2010) Role of the TLR signaling molecule TRIF in β-cell function and glucose homeostasis. Islets 2, 104-111.
28. Lee, J. Y., Zhao, L., Youn, H. S., Weatherill, A. R., Tapping, R., Feng, L., Lee, W. H., Fitzgerald, K. A., Hwang, D. H. (2004) Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J. Biol. Chem. 279, 16971-16979.
29. Muzio, M., Ni, J., Feng, P., Dixit, V. M. (1997) IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278, 1612-1615.
30. Lord, K. A., Hoffman-Liebermann, B., Liebermann, D. A. (1990) Complexity of the immediate early response of myeloid cells to terminal differentiation and growth arrest includes ICAM-1, Jun-B and histone variants. Oncogene 5, 387-396.
31. Hultmark, D. (1994) Macrophage differentiation marker MyD88 is a member of the Toll/IL-1 receptor family. Biochem. Biophys. Res. Commun. 199, 144-146.
32. Xia, Z. P., Sun, L., Chen, X., Pineda, G., Jiang, X., Adhikari, A., Zeng, W., Chen, Z. J. (2009) Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 461, 114-119.
33. Kumar, H., Kawai, T., Akira, S. (2009) Toll-like receptors and innate immunity. Biochem. Biophys. Res. Commun. 388, 621-625.
34. Takeuchi, O., Kaufmann, A., Grote, K., Kawai, T., Hoshino, K., Morr, M., Muhlradt, P. F., Akira, S. (2000) Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a Toll-like receptor 2-and MyD88-dependent signaling pathway. J. Immunol. 164, 554-557.
35. Arbibe, L., Mira, J. P., Teusch, N., Kline, L., Guha, M., Mackman, N., Godowski, P. J., Ulevitch, R. J., Knaus, U. G. (2000) Toll-like receptor 2-mediated NF-κ B activation requires a Rac1-dependent pathway. Nat. Immunol. 1, 533-540.
36. Dasu, M. R., Jialal, I. (2011) Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors. Am. J. Physiol. Endocrinol. Metab. 300, E145-E154.
37. Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., Flier, J. S. (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116, 3015-3025.
38. Pal, D., Dasgupta, S., Kundu, R., Maitra, S., Das, G., Mukhopadhyay, S., Ray, S., Majumdar, S. S., Bhattacharya, S. (2012) Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat. Med. 18, 1279-1285.
39. Saberi, M., Woods, N. B., de Luca, C., Schenk, S., Lu, J. C., Bandyopadhyay, G., Verma, I. M., Olefsky, J. M. (2009) Hematopoietic cell-specific deletion of Toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab. 10, 419-429.
40. Orr, J. S., Puglisi, M. J., Ellacott, K. L., Lumeng, C. N., Wasserman, D. H., Hasty, A. H. (2012) Toll-like receptor 4 deficiency promotes the alternative activation of adipose tissue macrophages. Diabetes 61, 2718-2727.
41. Konner, A. C., Bruning, J. C. (2011) Toll-like receptors: linking inflammation to metabolism. Trends Endocrinol. Metab. 22, 16-23.
42. De Luca, C., Olefsky, J. M. (2008) Inflammation and insulin resistance. FEBS Lett. 582, 97-105.
43. Caricilli, A. M., Nascimento, P. H., Pauli, J. R., Tsukumo, D. M., Velloso, L. A., Carvalheira, J. B., Saad, M. J. (2008) Inhibition of Toll-like receptor 2 expression improves insulin sensitivity and signaling in muscle and white adipose tissue of mice fed a high-fat diet. J. Endocrinol. 199, 399-406.
44. Kuo, L. H., Tsai, P. J., Jiang, M. J., Chuang, Y. L., Yu, L., Lai, K. T., Tsai, Y. S. (2011) Toll-like receptor 2 deficiency improves insulin sensitivity and hepatic insulin signalling in the mouse. Diabetologia 54, 168-179.
45. Ehses, J. A., Meier, D. T., Wueest, S., Rytka, J., Boller, S., Wielinga, P. Y., Schraenen, A., Lemaire, K., Debray, S., Van Lommel, L., Pospisilik, J. A., Tschopp, O., Schultze, S. M., Malipiero, U., Esterbauer, H., Ellingsgaard, H., Rutti, S., Schuit, F. C., Lutz, T. A., Boni-Schnetzler, M., Konrad, D., Donath, M. Y. (2010) Toll-like receptor 2-deficient mice are protected from insulin resistance and β cell dysfunction induced by a high-fat diet. Diabetologia 53, 1795-1806.
46. Senn, J. J. (2006) Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes. J. Biol. Chem. 281, 26865-26875.
47. Misra, D. P., Das, S., Sahu, P. K. (2012) Prevalence of inflammatory markers (high-sensitivity C-reactive protein, nuclear factor-κB, and adiponectin) in Indian patients with type 2 diabetes mellitus with and without macrovascular complications. Metab. Syndr. Relat. Disord. 10, 209-213.
48. Yan, S. F., Ramasamy, R., Schmidt, A. M. (2008) Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications. Nat. Clin. Pract. Endocrinol. Metab. 4, 285-293.
49. Devaraj, S., Jialal, I., Yun, J. M., Bremer, A. (2010) Demonstration of increased Toll-like receptor 2 and Toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications. Metabolism 60, 256-259.
50. Kim, F., Pham, M., Luttrell, I., Bannerman, D. D., Tupper, J., Thaler, J., Hawn, T. R., Raines, E. W., Schwartz, M. W. (2007) Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ. Res. 100, 1589-1596.
51. Higashimori, M., Tatro, J. B., Moore, K. J., Mendelsohn, M. E., Galper, J. B., Beasley, D. (2011) Role of Toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 31, 50-57.
52. Tarkowski, A., Bjersing, J., Shestakov, A., Bokarewa, M. I. (2010) Resistin competes with lipopolysaccharide for binding to Toll-like receptor 4. J. Cell. Mol. Med. 14, 1419-1431.
53. Mullick, A. E., Soldau, K., Kiosses, W. B., Bell III, T. A., Tobias, P. S., Curtiss, L. K. (2008) Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. J. Exp. Med. 205, 373-383.
54. Mullick, A. E., Tobias, P. S., Curtiss, L. K. (2005) Modulation of atherosclerosis in mice by Toll-like receptor 2. J. Clin. Invest. 115, 3149-3156.
55. Michelsen, K. S., Wong, M. H., Shah, P. K., Zhang, W., Yano, J., Doherty, T. M., Akira, S., Rajavashisth, T. B., Arditi, M. (2004) Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc. Natl. Acad. Sci. USA 101, 10679-10684.
56. Masini, M., Bugliani, M., Lupi, R., del Guerra, S., Boggi, U., Filipponi, F., Marselli, L., Masiello, P., Marchetti, P. (2009) Autophagy in human type 2 diabetes pancreatic beta cells. Diabetologia 52, 1083-1086.
57. Yin, J. J., Li, Y. B., Wang, Y., Liu, G. D., Wang, J., Zhu, X. O., Pan, S. H. (2012) The role of autophagy in endoplasmic reticulum stress-induced pancreatic beta cell death. Autophagy 8, 158-164.
58. Choi, S. E., Lee, S. M., Lee, Y. J., Li, L. J., Lee, S. J., Lee, J. H., Kim, Y., Jun, H. S., Lee, K. W., Kang, Y. (2009) Protective role of autophagy in palmitate-induced INS-1 β-cell death. Endocrinology 150, 126-134.
59. Chen, Z. F., Li, Y. B., Han, J. Y., Wang, J., Yin, J. J., Li, J. B., Tian, H. (2011) The double-edged effect of autophagy in pancreatic β cells and diabetes. Autophagy 7, 12-16.
60. Zhou, R., Yazdi, A. S., Menu, P., Tschopp, J. (2011) A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221-225.
61. Nakahira, K., Haspel, J. A., Rathinam, V. A., Lee, S. J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., Fitzgerald, K. A., Ryter, S. W., Choi, A. M. (2010) Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12, 222-230.
62. Harris, J., Hartman, M., Roche, C., Zeng, S. G., O'Shea, A., Sharp, F. A., Lambe, E. M., Creagh, E. M., Golenbock, D. T., Tschopp, J., Kornfeld, H., Fitzgerald, K. A., Lavelle, E. C. (2011) Autophagy controls IL-1β secretion by targeting pro-IL-1β for degradation. J. Biol. Chem. 286, 9587-9597.
63. Dupont, N., Jiang, S., Pilli, M., Ornatowski, W., Bhattacharya, D., Deretic, V. (2011) Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β. EMBO J. 30, 4701-4711.
64. Deretic, V. (2011) Autophagy in immunity and cell-autonomous defense against intracellular microbes. Immunol. Rev. 240, 92-104.
65. Xu, Y., Jagannath, C., Liu, X. D., Sharafkhaneh, A., Kolodziejska, K. E., Eissa, N. T. (2007) Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 27, 135-144.
66. Delgado, M. A., Elmaoued, R. A., Davis, A. S., Kyei, G., Deretic, V. (2008) Toll-like receptors control autophagy. EMBO J. 27, 1110-1121.
67. Rissanen, A., Howard, C. P., Botha, J., Thuren, T. (2012) Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial. Diabetes Obes. Metab. doi:10.1111/j.1463-1326.2012.01637.x [Epub ahead of print].
68. Tsukumo, D. M., Carvalho-Filho, M. A., Carvalheira, J. B., Prada, P. O., Hirabara, S. M., Schenka, A. A., Araujo, E. P., Vassallo, J., Curi, R., Velloso, L. A., Saad, M. J. (2007) Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56, 1986-1998.
69. Cheng, Q., Dong, W., Qian, L., Wu, J., Peng, Y. (2011) Visfatin inhibits apoptosis of pancreatic β-cell line, MIN6, via the mitogen-activated protein kinase/phosphoinositide 3-kinase pathway. J. Mol. Endocrinol. 47, 13-21.
70. Cha, J. J., Hyun, Y. Y., Lee, M. H., Kim, J. E., Nam, D. H., Song, H. K., Kang, Y. S., Lee, J. E., Kim, H. W., Han, J. Y., Cha, D. R. (2013) Renal protective effects of Toll-like receptor 4 signaling blockade in type 2 diabetic mice. Endocrinology 154, 2144-2155.
71. Tidswell, M., Tillis, W., Larosa, S. P., Lynn, M., Wittek, A. E., Kao, R., Wheeler, J., Gogate, J., Opal, S. M. (2010) Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis. Crit. Care Med. 38, 72-83.
72. Lucas, K., Maes, M. (2013) Role of the Toll like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway. Mol. Neurobiol. 48, 190-204.
73. Wu, Y., Li, W., Zhou, C., Lu, F., Gao, T., Liu, Y., Cao, J., Zhang, Y. (2012) Ketamine inhibits lipopolysaccharide-induced astrocytes activation by suppressing TLR4/NF-κB pathway. Cell. Physiol. Biochem. 30, 609-617.
74. Kanuri, G., Weber, S., Volynets, V., Spruss, A., Bischoff, S. C., Bergheim, I. (2009) Cinnamon extract protects against acute alcohol-induced liver steatosis in mice. J. Nutr. 139, 482-487.
75. Xu, Y., Liu, X. D., Gong, X., Eissa, N. T. (2008) Signaling pathway of autophagy associated with innate immunity. Autophagy 4, 110-112.